GLPwatch
Bile acid diarrhoea.
Ugeskr Laeger · 2023
Last updated 2026-05-28Bile acid diarrhoea is a condition where bile acids irritate the colon, causing diarrhoea and affecting about 1-2% of adults. Current treatment uses bile acid sequestrants, but a study found that the GLP-1 drug liraglutide may be more effective at reducing symptoms.
AI summary of the abstract below.
| Journal | Ugeskr Laeger, 2023 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
Abstract
Bile acid diarrhoea is a socially debilitating disease caused by irritation of the colonic mucosa due to a spillover of bile acids from the small intestine into the colon. Studies estimate a prevalence of 1-2% of the adult population, but many patients never seek help or are misdiagnosed. Bile acid diarrhoea is treated with bile acid sequestrants, however, new research shows superior effect on reported symptoms with the glucagon-like peptide 1 receptor agonist liraglutide.
Verbatim abstract via PubMed 37264870 ↗